OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society
Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
Comparative cardiovascular effectiveness of newer glucose-lowering drugs in elderly with type 2 diabetes: a target trial emulation cohort study
Vanja Kosjerina, Mojtaba Parsa, Stine H. Scheuer, et al.
EClinicalMedicine (2025) Vol. 82, pp. 103162-103162
Closed Access
Vanja Kosjerina, Mojtaba Parsa, Stine H. Scheuer, et al.
EClinicalMedicine (2025) Vol. 82, pp. 103162-103162
Closed Access
Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy
Tuğçe Çöllüoğlu, Ahmet Çelik, Naim Ata, et al.
International Journal of Cardiology (2024) Vol. 407, pp. 132109-132109
Closed Access | Times Cited: 2
Tuğçe Çöllüoğlu, Ahmet Çelik, Naim Ata, et al.
International Journal of Cardiology (2024) Vol. 407, pp. 132109-132109
Closed Access | Times Cited: 2
Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Dae Jung Kim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 837-846
Closed Access | Times Cited: 2
Ja Young Jeon, Dae Jung Kim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 837-846
Closed Access | Times Cited: 2
Individualized treatment of diabetes mellitus in older adults
Atsushi Araki
Geriatrics and gerontology international/Geriatrics & gerontology international (2024) Vol. 24, Iss. 12, pp. 1257-1268
Open Access | Times Cited: 2
Atsushi Araki
Geriatrics and gerontology international/Geriatrics & gerontology international (2024) Vol. 24, Iss. 12, pp. 1257-1268
Open Access | Times Cited: 2
Age-dependent association of discharge heart-failure medications with clinical outcomes in a super-aged society
Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113761-113761
Open Access | Times Cited: 10
Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113761-113761
Open Access | Times Cited: 10
Cardiovascular and renal outcomes with SGLT2 inhibitors: Real-life observational studies in older patients with type 2 diabetes
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 10, pp. 100135-100135
Open Access | Times Cited: 6
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 10, pp. 100135-100135
Open Access | Times Cited: 6
Sodium–glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure
Koshiro Kanaoka, Yoshitaka Iwanaga, Michikazu Nakai, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 5, pp. 444-452
Closed Access | Times Cited: 4
Koshiro Kanaoka, Yoshitaka Iwanaga, Michikazu Nakai, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 5, pp. 444-452
Closed Access | Times Cited: 4
The Prognostic Role of Spot Urinary Sodium and Chloride in a Cohort of Hospitalized Advanced Heart Failure Patients: A Pilot Study
Αndrew Xanthopoulos, Charalambos Christofidis, Chris Pantsios, et al.
Life (2023) Vol. 13, Iss. 3, pp. 698-698
Open Access | Times Cited: 3
Αndrew Xanthopoulos, Charalambos Christofidis, Chris Pantsios, et al.
Life (2023) Vol. 13, Iss. 3, pp. 698-698
Open Access | Times Cited: 3
Current status of real-world big data research in the cardiovascular field in Japan
Reina Tonegawa‐Kuji, Koshiro Kanaoka, Yoshitaka Iwanaga
Journal of Cardiology (2022) Vol. 81, Iss. 3, pp. 307-315
Closed Access | Times Cited: 3
Reina Tonegawa‐Kuji, Koshiro Kanaoka, Yoshitaka Iwanaga
Journal of Cardiology (2022) Vol. 81, Iss. 3, pp. 307-315
Closed Access | Times Cited: 3
Contemporary Use of β‐Blockers in Heart Failure Patients With and Without Atrial Fibrillation: A Nationwide Database Analysis
Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access
Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access
